葛兰素史克
GSK48.120USD
-0.290-0.60%
交易中 （美东）报价延迟15分钟
96.87B总市值
13.43市盈率 TTM
关于 葛兰素史克 公司
葛兰素史克 是一家全球性生物制药公司。该公司的部门包括商业运营和研发。该公司为卵巢癌、子宫内膜癌和多发性骨髓瘤等患者开发抗癌药物。其产品领域包括疫苗、特种药物和普通药物。该公司还专注于解决呼吸系统和炎症患者尚未满足的治疗需求。其疫苗组合包括 20 多种疫苗，可帮助保护人们免受一系列疾病和感染，包括脑膜炎、带状疱疹和流感等。其特种药物部门还致力于开发用于呼吸系统疾病和艾滋病毒的药物。其普通药物包括用于哮喘和慢性阻塞性肺病的吸入药物、抗生素和用于皮肤病的药物。该公司正在推进慢性乙型肝炎和脂肪肝以及肝病以外其他治疗领域的寡核苷酸疗法。
葛兰素史克简介
公司代码GSK
公司名称GSK plc
上市日期May 22, 1972
CEOMs. Deborah Waterhouse
员工数量68629
证券类型Ordinary Share
年结日May 22
公司地址980 Great West Road
城市BRENTFORD
上市交易所London Stock Exchange
国家United Kingdom
邮编TW8 9GS
电话442080475000
网址https://www.gsk.com/
公司代码GSK
上市日期May 22, 1972
CEOMs. Deborah Waterhouse
葛兰素史克公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Hal V. Barron, M.D.
Dr. Hal V. Barron, M.D.
Non-Executive Director
Non-Executive Director
658.41K
+0.49%
Ms. Shobie Ramakrishnan
Ms. Shobie Ramakrishnan
Chief Digital and Technology Officer
Chief Digital and Technology Officer
484.59K
+0.08%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Senior Independent Non-Executive Director
Senior Independent Non-Executive Director
38.91K
+0.88%
Ms. Elizabeth McKee (Liz) Anderson
Ms. Elizabeth McKee (Liz) Anderson
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
+0.87%
Dr. Jeannie Lee
Dr. Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Independent Non-Executive Director and Scientific & Medical Expert
1.58K
+0.83%
Dr. Harry C. (Hal) Dietz
Dr. Harry C. (Hal) Dietz
Independent Non-Executive Director, Scientific and Medical Expert
Independent Non-Executive Director, Scientific and Medical Expert
--
--
Mr. James Ford
Mr. James Ford
Senior Vice President, Group General Counsel, Legal and Compliance
Senior Vice President, Group General Counsel, Legal and Compliance
--
--
Ms. Sally Jackson
Ms. Sally Jackson
Senior Vice President - Global Communications and CEO Office
Senior Vice President - Global Communications and CEO Office
--
--
Dr. Tony Wood, Ph.D.
Dr. Tony Wood, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Julie Brown
Ms. Julie Brown
Chief Financial Officer, Executive Director
Chief Financial Officer, Executive Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Hal V. Barron, M.D.
Dr. Hal V. Barron, M.D.
Non-Executive Director
Non-Executive Director
658.41K
+0.49%
Ms. Shobie Ramakrishnan
Ms. Shobie Ramakrishnan
Chief Digital and Technology Officer
Chief Digital and Technology Officer
484.59K
+0.08%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Senior Independent Non-Executive Director
Senior Independent Non-Executive Director
38.91K
+0.88%
Ms. Elizabeth McKee (Liz) Anderson
Ms. Elizabeth McKee (Liz) Anderson
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
+0.87%
Dr. Jeannie Lee
Dr. Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Independent Non-Executive Director and Scientific & Medical Expert
1.58K
+0.83%
Dr. Harry C. (Hal) Dietz
Dr. Harry C. (Hal) Dietz
Independent Non-Executive Director, Scientific and Medical Expert
Independent Non-Executive Director, Scientific and Medical Expert
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
US
5.49B
51.53%
Rest of world
2.71B
25.44%
Europe
2.45B
23.03%
业务
地区
暂无数据
股东统计
更新时间: 8月17日 周日
更新时间: 8月17日 周日
持股股东
股东类型
持股股东
持股股东
占比
Dodge & Cox
3.88%
Fidelity Management & Research Company LLC
2.54%
Fisher Investments
1.54%
PRIMECAP Management Company
1.37%
JTC Employer Solutions Trusteee Ltd
0.72%
其他
89.96%
持股股东
持股股东
占比
Dodge & Cox
3.88%
Fidelity Management & Research Company LLC
2.54%
Fisher Investments
1.54%
PRIMECAP Management Company
1.37%
JTC Employer Solutions Trusteee Ltd
0.72%
其他
89.96%
股东类型
持股股东
占比
Investment Advisor
9.64%
Investment Advisor/Hedge Fund
7.38%
Research Firm
1.05%
Hedge Fund
0.83%
Bank and Trust
0.11%
Individual Investor
0.06%
Pension Fund
0.06%
Insurance Company
0.05%
Family Office
0.03%
其他
80.80%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1474
388.63M
19.14%
-11.70M
2025Q2
1478
378.08M
18.54%
+5.70M
2025Q1
1494
378.46M
18.50%
+5.08M
2024Q4
1481
355.06M
17.14%
+27.38M
2024Q3
1472
319.97M
15.44%
-30.07M
2024Q2
1585
322.06M
15.54%
-29.11M
2024Q1
1617
318.91M
15.39%
-23.52M
2023Q4
1614
299.81M
14.57%
-35.71M
2023Q3
1570
293.92M
14.35%
-37.46M
2023Q2
1545
286.58M
13.99%
-41.88M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
78.76M
3.87%
+106.04K
+0.13%
Jun 30, 2025
Fidelity Management & Research Company LLC
51.48M
2.53%
+872.19K
+1.72%
Jun 30, 2025
Fisher Investments
31.34M
1.54%
+1.31M
+4.35%
Jun 30, 2025
PRIMECAP Management Company
27.73M
1.36%
+2.02M
+7.85%
Jun 30, 2025
JTC Employer Solutions Trusteee Ltd
15.00M
0.74%
-262.98K
-1.72%
Jun 30, 2025
Fidelity Institutional Asset Management
9.53M
0.47%
+10.84K
+0.11%
Jun 30, 2025
T. Rowe Price International Ltd
8.05M
0.4%
+324.11K
+4.20%
Jun 30, 2025
RBC Capital Markets Wealth Management
6.99M
0.34%
+740.61K
+11.84%
Jun 30, 2025
State Street Investment Management (US)
6.71M
0.33%
-258.77K
-3.71%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
6.12M
0.3%
-2.36M
-27.84%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
VanEck Pharmaceutical ETF
4.72%
USCF Dividend Income Fund
4.6%
The Opal International Dividend Income ETF
4.11%
Sound Equity Dividend Income ETF
3.49%
Keating Active ETF
3.48%
Brandes International ETF
2.79%
Altrius Global Dividend ETF
2.42%
Fidelity Blue Chip Value ETF
1.52%
Fidelity Women's Leadership ETF
1.17%
Lattice Hartford Mltfctr Dev Mkts (ex-US) Str ETF
1.07%
查看更多
VanEck Pharmaceutical ETF
占比4.72%
USCF Dividend Income Fund
占比4.6%
The Opal International Dividend Income ETF
占比4.11%
Sound Equity Dividend Income ETF
占比3.49%
Keating Active ETF
占比3.48%
Brandes International ETF
占比2.79%
Altrius Global Dividend ETF
占比2.42%
Fidelity Blue Chip Value ETF
占比1.52%
Fidelity Women's Leadership ETF
占比1.17%
Lattice Hartford Mltfctr Dev Mkts (ex-US) Str ETF
占比1.07%
分红派息
近5年累计派现
20.79B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 05, 2025
GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025
Feb 21, 2025
Apr 10, 2025
Feb 21, 2025
Oct 30, 2024
GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024
Nov 15, 2024
Jan 09, 2025
Nov 15, 2024
Jul 31, 2024
GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Oct 10, 2024
Aug 16, 2024
May 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024
May 17, 2024
Jul 11, 2024
May 16, 2024
Feb 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024
Feb 23, 2024
Apr 11, 2024
Feb 22, 2024
Nov 01, 2023
GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023
Nov 17, 2023
Jan 11, 2024
Nov 16, 2023
Jul 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Oct 12, 2023
Aug 17, 2023
Apr 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023
May 19, 2023
Jul 13, 2023
May 18, 2023
Feb 01, 2023
GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023
Feb 24, 2023
Apr 13, 2023
Feb 23, 2023
Nov 02, 2022
GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022
Nov 18, 2022
Jan 12, 2023
Nov 17, 2022
查看更多
拆合股
公告日期
类型
比率
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
公告日期
类型
比率
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
Jun 24, 2022
Merger
5→4
